Seeking Alpha

Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced xM for treatment response monitoring ...
News Medical

RDT launches Tempus ALS monitor and defibrillator for smarter, more focused emergency response

Remote Diagnostic Technologies Ltd. (RDT), an innovator in pre-hospital care, today announced the launch of its Tempus ALS monitor and defibrillator at the Emergency Services Show in Birmingham.
News Medical

RDT to preview innovative Tempus ALS defibrillator monitor at MEDICA 2016

RDT, a leading provider of pre-hospital care solutions, will be previewing its Tempus ALS™ defibrillator monitor at MEDICA 2016. Visitors to Stand D70 in Hall 11 will be able to see this innovative ...
Nasdaq

Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, ...
Business Wire

Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with The Abrams ...